Moneycontrol
Get App
Last Updated : Apr 12, 2019 01:00 PM IST | Source: Moneycontrol.com

Dr. Reddy’s Laboratories Q4 PAT seen up 88.4% YoY to Rs. 512.7 cr: Prabhudas Lilladher

Net Sales are expected to increase by 12.4 percent Y-o-Y (up 3.4 percent Q-o-Q) to Rs. 3,994.3 crore, according to Prabhudas Lilladher.

Moneycontrol News @moneycontrolcom
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Prabhudas Lilladher has come out with its fourth quarter (January-March’ 19) earnings estimates for the Pharma sector. The brokerage house expects Dr. Reddy’s Laboratories to report net profit at Rs. 512.7 crore up 88.4% year-on-year (up 2.5% quarter-on-quarter).


Net Sales are expected to increase by 12.4 percent Y-o-Y (up 3.4 percent Q-o-Q) to Rs. 3,994.3 crore, according to Prabhudas Lilladher.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 45.3 percent Y-o-Y (up 1.8 percent Q-o-Q) to Rs. 818.8 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.



India Union Budget 2019: What does Finance Minister Nirmala Sitharaman have up her sleeve? Click here for top and latest Budget news, views and analyses.
First Published on Apr 12, 2019 01:00 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant